The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Annouces it Has Been Awarded a Phase II STTR Grant from the National Institute of General Medical Science, with Prof. Thomas Smithgall, University of Pittsburgh as the PI, Entitled "Small Molecule Inhibitors of HIV1 Nef Virulence Factor for Treatment of HIV AIDS"

 

Doylestown, PA. Augst 15, 2016- FCCDC is pleased to announce that it has been awarded a Phase II STTR grant from the National Institute of General Medical Science, with Prof. Thomas Smithgall, University of Pittsburgh as the Principal Investigator (R42GM112516-02). The Project Title is "Small Molecule Inhibitors of HIV1 Nef Virulence Factor for Treatment of HIV AIDS."